Hepatitis C: a critical analysis of therapeutic response predictors
Braz. j. infect. dis
; 6(2): 74-81, Apr. 2002.
Article
in English
| LILACS, Sec. Est. Saúde SP
| ID: lil-332307
Responsible library:
BR1.1
RESUMO
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology.
Full text:
Available
Collection:
National databases
/
Brazil
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
LILACS
/
Sec. Est. Saúde SP
Main subject:
Hepatitis C, Chronic
/
Drug Evaluation
Type of study:
Prognostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Braz. j. infect. dis
Year:
2002
Document type:
Article
Institution/Affiliation country:
Emílio Ribas Infectious Diseases Institute/BR